We recently reported an association between loss in T-cell receptor (TcR) z
eta-chain expression and tumor-induced apoptosis of T lymphocytes. In this
study, the possibility that zeta-chain serves as a direct substrate for act
ivated caspases was investigated. Here, we report that two DXXD motifs, whi
ch are putative recognition sequences for caspase-3-related proteases and a
re present in the amino acid sequence of the zeta-chain, are cleaved in apo
ptotic Jurkat T lymphocytes. Cleavage of zeta-chain in Jurkat cells ligated
by agonistic anti-Bas antibody was inhibited in the presence of peptide in
hibitors of caspases, including the pan-caspase inhibitor N-benzyloxycarbon
yl-Val-Ala-Asp-fluoromethyl ketone and N-benzyloxycarbonyl-Asp-Glu-Val-Asp-
fluoromethyl ketone, an inhibitor of caspase-3-like activity, Fas-induced c
leavage of zeta-chain was also inhibited in Jurkat cells overexpressing the
intracellular inhibitors of caspase activity, Bcl-2 or cytokine response-m
odifier A. In vitro translated zeta-chain was cleaved in a similar fashion
by recombinant caspase-3 or caspase-7 in a dose-dependent manner. In the pr
esence of N-benzyloxycarbonyl-Asp-Glu-Val-Asp-fluoromethyl ketone, no cleav
age of in vitro translated zeta-chain was observed. These results suggest t
hat the loss of TcR zeta-chain, previously associated with tumor-induced im
mune dysfunction and more recently associated with tumor-induced apoptosis
of T lymphocytes, is mediated by a direct degradation of the zeta-chain by
activated caspases, This is the first report of involvement of caspases in
degradation of the zeta protein.